Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENT-IT: Infection Prophylaxis in Total Joint Replacement
NCT05084378Phase 3Completed
- Sponsor
- McMaster University
- Start
- Mar 2022
- Primary completion
- Aug 2024
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Hydrogel Systems
- Countries
- 2
01
Overview
A Phase 3 trial of IVIEW-1502, chlorhexidine + cymenol gel, vancomycin in periprosthetic joint infection (PJI), sponsored by McMaster University. Started Mar 2022; status: completed.
02
Drugs
IVIEW-1502chlorhexidine + cymenol gelvancomycin
03
Conditions
periprosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT05084378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05084378.